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SObjective: Chylothorax resulting from thoracic duct damage is often difficult to identify and repair. We hypoth-
esized that near-infrared fluorescent light could provide sensitive, real-time, high-resolution intraoperative
imaging of thoracic duct anatomy and function.
Methods: In 16 rats, 4 potential near-infrared fluorescent lymphatic tracers were compared in terms of signal
strength and imaging time: indocyanine green, the carboxylic acid of IRDye 800CW (LI-COR, Lincoln,
Neb), indocyanine green adsorbed to human serum albumin, and IRDye 800CW conjugated covalently to human
serum albumin. Optimal agent was validated in 8 pigs approaching human size (n ¼ 6 by open surgery with
FLARE imaging system [Beth Israel Deaconess Medical Center, Boston, Mass] and n ¼ 2 by video-assisted
thoracoscopic surgery minimally invasive [m-FLARE] imaging system [Beth Israel Deaconess Medical Cen-
ter]). Lymphatic tracer injection site, dose, and timing were optimized.
Results: For signal strength, sustained imaging time, and clinical translatability, the best lymphatic tracer was
indocyanine green, which is already Food and Drug Administration approved for other indications. In pigs,
a simple subcutaneous injection of indocyanine green into lower leg (36 mg/kg), provided thoracic duct imag-
ing with onset of about 5 minutes after injection, sustained imaging for at least 60 minutes after injection, and
signal-to-background ratio of at least 2. With this technology, normal thoracic duct flow, collateral flow, injury
models, and repair models could all be observed under direct visualization.
Conclusions: Near-infrared fluorescent light could provide sensitive, sustained, real-time imaging of thoracic
duct anatomy and function during both open and video-assisted thoracoscopic surgery in animal models.
(J Thorac Cardiovasc Surg 2011;142:31-8)Supplemental material is available online.Thoracic duct injury, a rare but serious complication after
chest surgery and major neck dissections, carries a high mor-
tality in untreated patients.1-3 Intraoperative identification of
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The Journal of Thoracic and Creoperation. Because traditional conservative treatment of
thoracic duct injury has a high failure rate,1 intraoperative im-
age guidance is essential for proper surgical management.4
Currently, lymphangiography and lymphoscintigraphy
are available to preoperatively identify the site of thoracic
duct damage; however, these techniques do not permit
precise localization of the injured site.5-7 In addition,
preoperative anatomic information is difficult to transfer
directly to the intraoperative situation. In the past, blue
dyes or indocyanine green (ICG) injections have been
used,8-10 as well as an invasive injection procedure in
which popliteal lymph node, testicular parenchyma, or the
mesenteric lymph duct was used as the injection site.
Although oral administration of heavy cream before
surgery is sometimes performed to visualize chylous
leakage or to prevent injury to the thoracic duct, the
contrast provided is low and identification of the thoracic
duct can be difficult.11 Optical imaging with near-infrared
(NIR) fluorescence has the potential to solve all of these
problems (as reviewed in Frangioni12 and by Gioux
et al13). Indeed, thoracic duct NIR fluorescence imaging
with ICG has been reported previously for the detection
of chylous fistulas in the thoracic cavity.14
Intraoperative, real-time NIR fluorescence imaging has
been used in many areas of surgery to visualize surgicalardiovascular Surgery c Volume 142, Number 1 31
Abbreviations and Acronyms
CW800-CA ¼ IRDye 800CW carboxylate
FDA ¼ Food and Drug Administration
FI ¼ fluorescence intensity
FLARE ¼ Fluorescence-Assisted Resection
and Exploration [system]
HSA ¼ human serum albumin
HSA800 ¼ IRDye 800CW conjugated with
human serum albumin
ICG ¼ indocyanine green
ICG-HSA ¼ indocyanine green adsorbed to
human serum albumin
m-FLARE ¼ Minimally Invasive Fluorescence-
Assisted Resection and
Exploration [system]
NIR ¼ near-infrared
SBR ¼ signal-to-background ratio
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Sanatomy and tissue function simultaneously and noninva-
sively with high spatial resolution. The enabling technology
for our study is the Fluorescence-Assisted Resection and
Exploration (FLARE) NIR optical imaging system (Beth Is-
rael Deaconess Medical Center, Boston, Mass),15 which
provides simultaneous acquisition of color video and 2 in-
dependent channels of invisible NIR fluorescence, 1 cen-
tered at 700 nm and the other at 800 nm, and the new,
minimally invasive version of FLARE, (m-FLARE), for
video-assisted thoracoscopic surgery. In this study, we hy-
pothesized that these NIR imaging systems might provide
adequate contrast for anatomic and functional assessment
of the thoracic duct after a simple subcutaneous injection.
We also sought to optimize the lymphatic tracer, injection
site, dose, and timing for the intraoperative assessment of
the thoracic duct.MATERIALS AND METHODS
Lymph Tracer Preparation
Pharmaceutical grade ICGwas purchased fromAkorn (Akorn, Incorpo-
rated, Lake Forest, Ill). ICG has been widely used in such clinical applica-
tions as liver function testing, cardiac output monitoring, and ophthalmic
angiography. Recently, it has also been used in image-guided surgery stud-
ies to assess vessel patency after anastomoses in coronary artery bypass
grafting16 and to evaluate perforator location and flap perfusion in breast
reconstructive surgery after mastectomy.17 The carboxylic acid form of IR-
Dye 800CW (CW800-CA) was purchased from LI-COR Biotechnology
(Lincoln, Neb). Both were diluted in phosphate-buffered saline solution
(pH 7.4) before injection. The noncovalent adsorption of ICG to human se-
rum albumin (HSA), at a molar ratio of 1:1 (ICG-HSA), was performed as
described previously.18 The covalent conjugation of IRDye 800CW toHSA
at a fluorophore to protein substitution ratio of 3.0 (HSA800) was prepared
as described previously.18 The optical properties of all agents were mea-
sured in fetal bovine serum. The quantum yields of contrast agents in fetal
bovine serum were calculated with ICG in dimethyl sulfoxide (quantum32 The Journal of Thoracic and Cardiovascular Surgeyield 13%19) as the calibration standard. For in vitro optical property mea-
surements, online fiberoptic HR2000 absorbance (200–1100 nm) and
USB2000FL fluorescence (350–1000 nm) spectrometers (Ocean Optics,
Inc, Dunedin, Fla) were used. NIR excitation was provided by a 770-nm
NIR laser diode light source (Electro Optical Components, Inc, Santa
Rosa, Calif) set to 8 mW and coupled through a 300-mm core diameter,
0.22 NA fiber (Fiberguide Industries Inc, Stirling, NJ).
Animal Studies
Animal studies were performed under the supervision of approved insti-
tutional protocols. Sixteen male 300-g Sprague–Dawley rats (Taconic
Farms, Germantown, NY)were anesthetized with 65-mg/kg intraperitoneal
pentobarbital and were ventilated by tracheotomy. Eight female Yorkshire
pigs (E.M. Parsons and Sons, Hadley, Mass) averaging 36.1 kg were in-
duced with 4.4-mg/kg intramuscular tiletamine hydrochloride and zolaze-
pam hydrochloride (Telazol; Fort Dodge Animal Health, Fort Dodge,
Iowa), intubated, and maintained with 2% isoflurane. Selective ventilation
of the left lung was used to deflate the right lung and help provide better
visualization of the thoracic duct. Electrocardiogram, heart rate, oxygen
saturation, and body temperature were monitored throughout the experi-
ment.
Optimization of Lymphatic Tracer in Rat
In 16 anesthetized rats, 50 mL of 10-mmol/L contrast agent (1.5 mg/kg
administered dose) was injected into mesenteric lymph nodes. For visual-
ization of the thoracic duct, a right thoracotomy was performed under con-
trolled ventilation to expose the posterior mediastinum near the spinal
column. The FLARE imaging system15 was used for quantification of
NIR fluorescence images. Intensities of the thoracic duct were measured
at 3, 5, 10, and 15 minutes after injection. The signal-to-background ratio
(SBR) was defined as the NIR fluorescence intensity (FI) of a region of in-
terest over the thoracic duct divided by that of an equivalent size and shape
region of interest over the thoracic wall.Optimization of ICG Injection Site, Dose, and
Imaging Time in Pig
Eight pigs were anesthetized as described previously and placed in a left
lateral decubitus position. A right thoracotomy was performed for open
surgery (n¼ 6). Three small (2–3 cm) incisions were made in the right cos-
tal interspaces for video-assisted thoracoscopic surgery (n ¼ 2). The inci-
sion positions included the midaxillary line at the 5th intercostal space,
anterior axillary line at the 7th intercostal space, and posterior axillary
line at the 7th intercostal space. The thoracoscope and surgical instruments
were inserted through these incisions. An additional incision was made to
retract the lung lobe or diaphragm if necessary.
After the inferior pulmonary ligament was divided, the thoracic duct
was visualized with the FLARE or m-FLARE imaging systems. Fluoro-
phore was injected subcutaneously into the groin (near, but not in groin
lymph nodes), the thigh (near the great saphenous vein detected by ultraso-
nography or palpation), and the shin (near the great saphenous vein). Con-
trol injections were made directly into groin lymph nodes exposed by
dissection. Fluorophore injections (n ¼ 3 per condition) could be repeated
every 2 hours to minimize the number of animals needed. In 3 pigs per con-
dition, 50 g of heavy cream was administered into the stomach or 1 cc of
undiluted methylene blue was administered directly into a groin lymph
node, and the thoracic duct was imaged over time.
To assess the affect of injected dose on SBR, the specified doses were
injected into the optimal injection site (n ¼ 3 per dose). After each injec-
tion, gentle massage was performed for 5 minutes to cause smooth migra-
tion of fluorophore. For quantitative assessment, images were recorded at
the time of injection (T¼ 0 minutes), then at 5, 10, 15, 30, 45, and 60 min-
utes after injection. At each time point, the FI of a region of interest over the
thoracic duct and thoracic wall were quantified with custom software. Thery c July 2011
TABLE 1. Physical and optical properties of near-infrared fluorescent lymphatic tracers in fetal bovine serum
Lymphatic
tracer
Molecular
weight
Hydrodynamic
diameter
Peak
absorbance
Peak
fluorescence
Quantum
yield* Description
ICG 776 Da 1.2 nm 807 nm 822 nm 9.3% Small molecule, FDA approved for cardiac and hepatic
function studies
CW800-CA 1069 Da 1.3 nm 786 nm 800 nm 14.2% Tetra-sulphonated heptamethine indocyanine small
molecule with improved quantum yield
ICG-HSA 67 kDa 7.3 nm 800 nm 814 nm 9.4% Noncovalent adsorption of ICG to human serum albumin
(1:1 molar ratio)
HSA800 70 kDa 7.4 nm 784 nm 802 nm 12.1% Covalent conjugation of CW800 to human serum
albumin (3:1 molar ratio)
ICG, Indocyanine green; FDA, Food and Drug Administration; CW800-CA, IRDye 800CW carboxylate; ICG-HSA, indocyanine green adsorbed to human serum albumin;
HSA800, IRDye 800CW conjugated with human serum albumin. *Quantum yield in fetal bovine serum supplemented with 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesul-
fonic acid (pH 7.4), relative to ICG in dimethyl sulfoxide (13%).
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background, derived as SBR ¼ ROIFI/ BGFI, where ROIFI indicates the
FI of the region of interest and BGFI denotes the FI of the background.
For the injury and treatment model, the pleura between the azygos vein
and the spinewas opened and the thoracic duct was exposed. Next, thoracic
duct injury was induced with a 20-gauge spinal needle and repaired by li-
gation with a 3-0 silk suture above and below the injury site.
NIR Fluorescence Imaging System
The FLARE imaging system has been described in detail previously.20
Our experiments used 40,000 lux of white light (400–650 nm), 4.0 mW/
cm2 of 670-nm NIR fluorescence excitation light, and 11.0 mW/cm2 of
760-nm NIR fluorescence excitation light. NIR fluorescence camera expo-
sure time was 67 ms or shorter. In the color–NIR merge images, 800-nm
NIR fluorescencewas pseudocolored green and overlaid on top of the color
video image.ICG
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FIGURE 1. Quantitative assessment of various near-infrared lymphatic tracers
over time in the thoracic duct of rats after injection of 1.5-mg/kg doses of the sp
animals for each contrast agent studied). ICG, Indocyanine green;CW800-CA, IR
serum albumin; HSA800, IRDye 800CW conjugated with human serum album
The Journal of Thoracic and Cm-FLARE Imaging System Components
The initial endoscopic imaging system has been described in detail
previously.21,22 The current version of m-FLARE introduced in this
study used white light from a custom 300-W xenon light source
(Wilson Associates, Weymouth, Mass) equipped with filtration to
remove all NIR, NIR excitation light from a 1-W 670-nm and 2.5-W
760-nm laser diode assembly (OZ Optics, Ottawa, Ontario, Canada)
combined with a custom light mixer (Qioptiq Imaging Solutions,
Fairport, NY) and a 0.6-NA fiber optic cable connected to a standard
rigid laparoscope (10 mm diameter, 0; Karl Storz GmbH & Co. KG,
Tuttlingen, Germany). Optimal distance between laparoscope and the
surgical field was 10 cm. Through the laparoscope, 30,000 lux of white
light (400–650 nm), 6.0 mW/cm2 of 670-nm NIR fluorescence
excitation light, and 20.0-mW/cm2 of 760-nm NIR fluorescence
excitation light were generated over a 5-cm diameter field of view. The
eyepiece of the laparoscope was attached to custom optics (QioptiqCW800-CA
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for thoracic duct imaging. Signal-to-background ratio (SBR,mean SEM)
ecified lymphatic tracers into mesenteric lymph nodes (n ¼ 4 independent
Dye 800CWcarboxylate; ICG-HSA, indocyanine green adsorbed to human
in.
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FIGURE 2. Thoracic duct imaging during open surgery in pigs. A, Signal-to-background ratio (SBR, mean  SEM) of the thoracic duct over time for
different injection sites (left, n ¼ 3 per condition) and different injection doses (right, n ¼ 3 per condition). Statistical assessments of the groin lymph
node (LN) versus the lower leg, the groin lymph node versus the thigh, and the groin lymph node versus the groin subcutaneum (left) are shown. Statistical
assessment of the various doses (36, 71, and 143 mg/kg) and the difference between 7.1 mg/kg and 71 mg/kg (right) are also shown. Asterisk indicates P<.05;
double asterisk indicates P<.01; and triple asterisk indicates P<.001, all by Tukey multiple comparison test. B, Comparison of typical contrast achieved
with orally administered heavy cream, methylene blue, and indocyanine green (ICG). Before injection (Pre-inj., top row), the thoracic duct is not visible.
After heavy cream (second row), the thoracic duct (white arrows) appears milky white. After methylene blue injection into a groin lymph node (third row),
the thoracic duct (white arrows) has a bluish tint, much like the azygos vein (Az.V). After subcutaneous injection of 71 mg/kg of indocyanine green into the
lower leg (bottom row), the thoracic duct (arrows) is visualized in high contrast with near-infrared (NIR) fluorescence. Shown are representative images from
n¼ 3 pigs per condition: color video (left), near-infrared fluorescence (middle), and a pseudocolored (lime green)merge (right). Scale bar represents 1 cm.
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video and NIR light with a scA640-74gc (Basler AG, Ahrensburg,
Germany) color charge-coupled device camera and a GC655 (Prosilica,
Stadtroda, Germany) NIR camera. Only the 800-nm emission channel
was needed to image ICG.
Statistical Analysis
An analysis of variance and Tukey multiple comparison test were used
to determine statistical differences between multiple groups. Tukey multi-
ple comparison test and analysis of variancewere used to show the pair that
displayed significant difference among the group. The analyzed values are
described as mean  SEM. All analyses were performed with GraphPad
Prism software (version 4.0; GraphPad Software Inc, La Jolla, Calif).34 The Journal of Thoracic and Cardiovascular SurgeRESULTS
Optical Properties
The physical and optical properties of the NIR fluores-
cent lymphatic tracers tested for thoracic duct imaging are
detailed in Table 1. ICG is a disulfonated heptamethine in-
docyanine small molecule that is already approved by the
Food and Drug Administration (FDA) for cardiac output
and hepatic function studies, as well as for ophthalmic an-
giography. It has an extremely small hydrodynamic diame-
ter, which allows it to travel through lymph nodes and into
the thoracic duct. CW800-CA is a new and improvedry c July 2011
FIGURE 3. High-resolution imaging of thoracic duct anatomy and function. Shown are representative images 30 minutes after injection of 36-mg/kg
indocyanine green into the lower leg of pigs. Conditions included normal flow (top row), collateral flow (second row, solid arrow), an injury model
(third row, dotted arrow), and image-guided repair of the thoracic duct (bottom row, arrowheads). Shown are color video (left), near-infrared (NIR)
fluorescence (middle), and a pseudocolored (lime green) merge (right). Lu, Lung; Ao, aorta; TD, thoracic duct; Es, esophagus; Az, azygos vein. Scale
bar represents 1 cm.
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Sheptamethine indocyanine small molecule with higher
quantum yield and lower protein binding.18 ICG-HSA is
the adsorption of ICG to a moderate-affinity binding site
on HSA. This complex is stable enough to permit sentinel
lymph node mapping, but at only 7.3 nm in hydrodynamic
diameter it can also pass through lymph nodes over time.18
We studied this complex with the hope that a larger hydro-
dynamic diameter would slow the rate of travel through the
lymphatic system and permit thoracic duct imaging for
a longer period. HSA800 is an improved NIR fluorescent al-
bumin derivative with higher quantum yield and stability.18
Thoracic Duct Imaging and Lymphatic Tracer
Performance in Rats
We found several differences among the NIR fluorescent
contrast agents with respect to SBR of the thoracic duct and
the period of optimal visualization. With a 15-minute visu-
alization period, ICG demonstrated SBR values of 4 to 5,
which remained relatively constant (Figure 1). Despite
a higher quantum yield of CW800-CA, which is supposed
to cause higher FI, or the larger hydrodynamic diameter
of ICG-HSA, the SBR values of both at 3 minutes after in-
jection were close to that of ICG and decayed significantly
during the 15-minute imaging interval (Figure 1). TheseThe Journal of Thoracic and Cresults are likely explained by rapid uptake into the blood-
stream (CW800-CA) or desorption of ICG from HSA
(ICG-HSA). We found that HSA800 showed the highest
SBR values, although not statistically significantly differ-
ent from those of ICG. Because HSA800 is not available
for clinical translation, ICG was used in all subsequent
experiments.
Quantitative Assessment of ICG Injection Site, Dose,
and Imaging Period in Pigs
Becausemesenteric lymphnodeinjectionisnotareasonable
clinical option, we attempted to find a more suitable injection
site. We injected 1 mL of a 3.2-mmol/L ICG solution (71 mg/
kg) into the groin, thigh, or lower leg of pigs. As shown in
Figure 2,A, injection into the groinworked poorlywithout ad-
vance exposure of groin lymph nodes and direct injection.
Direct injection into already exposed groin lymph nodes
served as a control and provided rapid and bright thoracic
duct imaging (Figure 2, A). Simple subcutaneous injection
into the thigh or lower leg (Figure 2, A, and Figure E1), how-
ever, provided acceptably high SBR values for as long as 120
minutes after injection (FigureE2).Although therewas no sta-
tistically significant differencebetween the thigh and lower leg
sites (P>.05), the lower leg site produced a higher SBR andardiovascular Surgery c Volume 142, Number 1 35
FIGURE 4. Near-infrared (NIR) fluorescence imaging of the thoracic duct with m-FLARE and video-assisted thoracoscopic surgery. A, Light paths and
system components of the m-FLARE imaging system for video-assisted thoracoscopic surgery. B, Video-assisted thoracoscopic surgery–based m-FLARE
imaging of the thoracic duct. Shown are representative images 30 minutes after injection of 36-mg/kg indocyanine green into the lower leg of pigs (n ¼ 2).
Conditions included normal flow (top row), collateral flow (second row, solid arrow), an injury model (third row, dotted arrow), and image-guided repair of
the thoracic duct (bottom row, arrowheads). Shown are color video (left), near-infrared fluorescence (middle), and a pseudocolored (lime green) merge
(right). TD, Thoracic duct, Ao, aorta, Az, azygos vein. Scale bar represents 1 cm.
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Swas chosen for further study. In comparisonwith ICG, oral ad-
ministration of heavy cream or injection ofmethylene blue di-
rectly into a groin lymph node provided relatively poor
contrast (Figure 2, B). In the latter case, differentiation of the
thoracic duct from the azygos vein was difficult.
To optimize the dose, 0.1 mL of 3.2-mmol/L ICG (7.1
mg/kg), 0.5 mL of 3.2-mmol/L ICG (36 mg/kg), 1.0 mL of
3.2-mmol/L ICG (71 mg/kg), and 2.0 mL of 3.2-mmol/L
ICG (143 mg/kg) were injected subcutaneously into the
lower leg, and the thoracic duct was imaged over time.
All doses provided SBR values of at least 2 except for the
7.1-mg/kg dose. Although SBR trended higher with increas-
ing dose (Figure 2, A), there was no statistically significant
difference among 36-mg/kg, 71-mg/kg, and 143-mg/kg doses
(P>.05).
Real-Time Imaging of Normal Flow, Injury, and
Repair in the Thoracic Duct of Pigs
With injection of 36-mg/kg of ICG into the lower leg, pul-
satile flow and collateral flow within the thoracic duct could
be assessed in real time (Figure 3). Similarly, if the thoracic
duct was injured, intraoperative NIR fluorescence imaging
provided immediate localization of the injury, and repair
could be performed under image guidance (Figure 3). Addi-
tionally, in the color image, ICG did not stain the surgical
field even after injury, because it was significantly diluted
during the long migration from the injection site.
NIR Fluorescence Video-Assisted Thoracoscopic
Surgery Imaging of the Thoracic Duct
The minimally invasive m-FLARE imaging system
(Figure 4, A) provided similar imaging capabilities to those
seen during open surgery with FLARE. As shown in
Figure 4, B, m-FLARE permitted real-time visualization
of the thoracic duct under conditions of normal flow, collat-
eral flow, injury, and repair.
DISCUSSION
This study exploited invisible NIR fluorescent light and
the contrast agent ICG, which is already FDA-approved
for other indications, to provide surgeons with real-time, in-
traoperative identification of the thoracic duct during both
open and minimally invasive surgical procedures. Cur-
rently, preoperative administration of heavy cream is used
to detect fistulas during video-assisted thoracoscopic
surgical ligation of the thoracic duct; however, heavy cream
provides poor contrast (Figure 2, B). In contrast, a properly
chosen NIR fluorescent lymphatic tracer, used in conjunc-
tion with an appropriate imaging system, can provide highly
sensitive visualization.
In this study, ICG provided an excellent SBR and a long
visualization time after a single subcutaneous injection of
at least 36 mg/kg into the lower leg without changing surgi-
cal field. Because of the availability of NIR imagingThe Journal of Thoracic and Csystems, such as the FLARE, m-FLARE, SPY (Novadaq
Technologies Inc, Mississauga, Ontario, Canada),16 and
PDE (Hamamatsu Photonics, Hamamatsu, Japan),23 and
the existing FDA approval for ICG in other indications,
future clinical trials should focus on optimizing dose and in-
jection site in patients with our data from swine as a starting
point.
A key variable in lymphatic tracer optimization is the
trade-off between contrast agent concentration at the injec-
tion site and dilution as the tracer flows through lymphatic
channels. The higher the injected concentration, the lower
the total fluorescence as a result of quenching. As the tracer
travels through lymphatic channels andgets diluted in lymph,
however, the NIR fluorescence signal becomes brighter and
brighter. The key to successful imaging in patients will re-
quire delineation of a volume of ICG that does not cause tat-
tooing at the injection site, a concentration of ICG that results
in maximal SBR in the thoracic duct, and proper timing after
injection for optimal thoracic duct contrast.
The best injection site in patients remains to be deter-
mined. The webbed space between the first and second
toes of the foot is often used as the injection site for lymph-
angiography.24 Such a long distance from the thoracic duct
will cause significant dilution of ICG, however, and thus
will result in lower SBR. Injection into the upper leg could
be problematic, however, because Schacht and colleagues25
have reported that there exists a narrow and deep plane of
subcutaneous fat that is not present in the lower leg or dor-
sum of the foot. Such subcutaneous fat could impede the
flow of ICG into lymphatic channels (see, for example,
the groin injection in Figure 2, A).
In summary, we have demonstrated high-sensitivity, real-
time visualization of the thoracic duct with invisible NIR
fluorescence light. Imaging is performed with an agent
already FDA approved for other indications, making trans-
lation to the clinic both feasible and practical.
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FIGURE E1. Thoracic duct imaging during open surgery in pigs. Lymphatic flow away from the injection site for 71 mg/kg of indocyanine green injected
subcutaneously into the groin (top row), thigh (middle row), and lower leg (bottom row). Shown are color video images (left), near-infrared (NIR) fluores-
cence images (middle), and a pseudocolored (lime green) merge (right). Arrowhead indicates the injection site. Scale bar represents 1 cm.
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FIGURE E2. Thoracic duct imaging during open surgery in pigs. Visualization of the thoracic duct over time in pigs after subcutaneous injection of
71 mg/kg of indocyanine green into the lower leg. Shown are representative images from before injection (Pre-Inj.) through 120 minutes after injection:
Color video (left), near-infrared (NIR) fluorescence (middle), and a pseudocolored (lime green) merge (right). Scale bar represents 1 cm.
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